Literature DB >> 24504128

Vision restoration training for glaucoma: a randomized clinical trial.

Bernhard A Sabel1, Julia Gudlin1.   

Abstract

IMPORTANCE Visual field loss due to retinal damage is considered irreversible, and methods are needed to achieve vision restoration. Behavioral vision training, shown to improve visual fields in hemianopia and optic nerve damage, might comprise such a method. OBJECTIVE To determine if behavioral activation of areas of residual vision using daily 1-hour vision restoration training for glaucoma for 3 months improves detection accuracy compared with placebo. DESIGN AND SETTING Prospective, double-blind, randomized, placebo-controlled clinical trial in an ambulatory care and home training setting. PARTICIPANTS Volunteer sample of patients with glaucoma (mean age, 61.7 years; age range, 39-79 years) with stable visual fields and well-controlled intraocular pressure. After randomization, 4 patients withdrew from the trial because of mild headaches (n = 2) or lack of time to complete the schedule (n = 2). INTERVENTIONS Computer-based vision restoration training for glaucoma (n = 15) or visual discrimination placebo training in the intact visual field (n = 15). MAIN OUTCOMES AND MEASURES The primary end point was change in detection accuracy in high-resolution perimetry. Secondary end points were 30° white-on-white and 30° blue-on-yellow near-threshold perimetry, as well as reaction time, eye movements, and vision-related and health-related quality of life. RESULTS Vision restoration training for glaucoma led to significant detection accuracy gains in high-resolution perimetry (P = .007), which were not found with white-on-white or blue-on-yellow perimetry. Furthermore, the pre-post differences after vision restoration training for glaucoma were greater compared with placebo in all perimetry tests (P = .02 for high-resolution perimetry, P = .04 for white on white, and P = .04 for blue on yellow), and these results were independent of eye movements. Vision restoration training for glaucoma (but not placebo) also led to faster reaction time (P = .009). Vision-related quality of life was unaffected, but the health-related quality-of-life mental health domain increased in both groups. CONCLUSIONS AND RELEVANCE Visual field defects caused by glaucoma can be improved by repetitively activating residual vision through training the visual field borders and areas of residual vision, thereby increasing their detection sensitivity. Our randomized clinical trial revealed evidence that visual field loss is in part reversible by behavioral, computer-based, online controlled vision training, comprising a new rehabilitation treatment option in glaucoma. Neuroplasticity of the visual cortex or higher cortical areas is the proposed mechanism of action. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT01799707.

Entities:  

Mesh:

Year:  2014        PMID: 24504128     DOI: 10.1001/jamaophthalmol.2013.7963

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  15 in total

1.  Phase 1b Randomized Controlled Study of Short Course Topical Recombinant Human Nerve Growth Factor (rhNGF) for Neuroenhancement in Glaucoma: Safety, Tolerability, and Efficacy Measure Outcomes.

Authors:  Gala Beykin; Laurel Stell; Muhammad Sohail Halim; Mariana Nuñez; Lilia Popova; Bac T Nguyen; Sylvia L Groth; Amy Dennis; Zhongqiu Li; Melissa Atkins; Tom Khavari; Sophia Y Wang; Robert Chang; Ann C Fisher; Yasir J Sepah; Jeffrey L Goldberg
Journal:  Am J Ophthalmol       Date:  2021-11-13       Impact factor: 5.488

Review 2.  Neuroprotective strategies for retinal disease.

Authors:  Machelle T Pardue; Rachael S Allen
Journal:  Prog Retin Eye Res       Date:  2018-02-23       Impact factor: 21.198

Review 3.  Mental stress as consequence and cause of vision loss: the dawn of psychosomatic ophthalmology for preventive and personalized medicine.

Authors:  Bernhard A Sabel; Jiaqi Wang; Lizbeth Cárdenas-Morales; Muneeb Faiq; Christine Heim
Journal:  EPMA J       Date:  2018-05-09       Impact factor: 6.543

4.  Low vision rehabilitation for better quality of life in visually impaired adults.

Authors:  Ruth Ma van Nispen; Gianni Virgili; Mirke Hoeben; Maaike Langelaan; Jeroen Klevering; Jan Ee Keunen; Ger Hmb van Rens
Journal:  Cochrane Database Syst Rev       Date:  2020-01-27

5.  A matter of time: improvement of visual temporal processing during training-induced restoration of light detection performance.

Authors:  Dorothe A Poggel; Bernhard Treutwein; Bernhard A Sabel; Hans Strasburger
Journal:  Front Psychol       Date:  2015-02-11

6.  Vision restoration in glaucoma: Nihilism and optimism at the crossroads.

Authors:  Muneeb A Faiq
Journal:  Oman J Ophthalmol       Date:  2016 Sep-Dec

7.  Alternating Current Stimulation for Vision Restoration after Optic Nerve Damage: A Randomized Clinical Trial.

Authors:  Carolin Gall; Sein Schmidt; Michael P Schittkowski; Andrea Antal; Géza Gergely Ambrus; Walter Paulus; Moritz Dannhauer; Romualda Michalik; Alf Mante; Michal Bola; Anke Lux; Siegfried Kropf; Stephan A Brandt; Bernhard A Sabel
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

Review 8.  Visual rehabilitation: visual scanning, multisensory stimulation and vision restoration trainings.

Authors:  Neil M Dundon; Caterina Bertini; Elisabetta Làdavas; Bernhard A Sabel; Carolin Gall
Journal:  Front Behav Neurosci       Date:  2015-07-27       Impact factor: 3.558

Review 9.  Ocular manifestations of Sturge-Weber syndrome: pathogenesis, diagnosis, and management.

Authors:  Flavio Mantelli; Alice Bruscolini; Maurizio La Cava; Solmaz Abdolrahimzadeh; Alessandro Lambiase
Journal:  Clin Ophthalmol       Date:  2016-05-13

Review 10.  Effects of alternating current stimulation on the healthy and diseased brain.

Authors:  Aini Ismafairus Abd Hamid; Carolin Gall; Oliver Speck; Andrea Antal; Bernhard A Sabel
Journal:  Front Neurosci       Date:  2015-10-27       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.